Skip to main content

ACELYRIN, Inc.

SLRNDelisted May 21, 2025
Industry
Pharmaceutical Preparations
SEC CIK
0001962918

ACELYRIN, Inc. was delisted on May 21, 2025; its insiders filed their last Form 4 on May 23, 2025; 106 institutions reported holding it in 13F filings for Q1 2025, worth $182.6M in total; no superinvestor held it.

Holders of 5% or more of SLRN

Holders whose latest Schedule 13D or 13G filing reports 5% or more of ACELYRIN, Inc., largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of SLRN
HolderLatest formStakeChangeFirst filedLatest filingFiling
Madison Avenue Partners, LP13D5.10%5.09M sharesNewApr 30, 20251 filingApr 30, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

15 Schedule 13D and 13G filings on ACELYRIN, Inc., newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on SLRN
Filed (ET)FilerFormStakeChangeEvent dateFiling
May 27, 20258:56 AM ETTrium Capital LLP13D/A0.00%0 shares–Below 5%May 23, 2025SEC
May 23, 20254:15 PM ETTang Capital Management LLCand 6 others13D/A0.00%0 shares−8.80 ppfrom 8.80%Below 5%May 21, 2025SEC
May 23, 20254:15 PM ETAyurMaya Capital Management Company, LPand 1 other13G/A0.00%0 shares–Below 5%May 21, 2025SEC
May 23, 20254:01 PM ETAccess Industries Management, LLCand 3 others13D/A0.00%0 shares−5.08 ppfrom 5.08%Below 5%May 21, 2025SEC
Apr 30, 20258:27 PM ETMadison Avenue Partners, LPand 5 others13D5.10%5.09M sharesNewApr 29, 2025SEC
Apr 29, 20251:50 PM ETTrium Capital LLP13D/A––Mar 6, 2025SEC
Mar 12, 20255:58 PM ETTang Capital Management LLCand 6 others13D/A8.80%8.82M shares+1.50 ppfrom 7.30%Mar 10, 2025SEC
Mar 7, 202512:49 PM ETT. Rowe Price Investment Management, Inc.13G/A4.60%4.65M shares−8.20 ppfrom 12.80%Below 5%Feb 28, 2025SEC
Mar 6, 202511:55 AM ETTrium Capital LLP13D5.40%5.39M sharesNewMar 6, 2025SEC
Feb 27, 20257:02 PM ETTang Capital Management LLCand 6 others13D/A7.30%7.30M shares+2.00 ppfrom 5.30%Feb 25, 2025SEC
Feb 20, 20254:15 PM ETTang Capital Management LLCand 6 others13D5.30%5.30M sharesNewFeb 18, 2025SEC
Feb 14, 20256:13 PM ETCitadel Advisors LLCand 6 others13G/A4.20%4.22M shares–Below 5%Dec 31, 2024SEC
Feb 14, 20259:45 AM ETT. Rowe Price Investment Management, Inc.13G/A12.80%12.9M shares–Dec 31, 2024SEC
Feb 10, 20255:14 PM ETAccess Industries Management, LLCand 3 others13D/A5.08%5.10M shares–Feb 6, 2025SEC
Feb 10, 20254:08 PM ETIntegrated Core Strategies (US) LLCand 3 others13G/A4.70%4.71M shares–Below 5%Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell ACELYRIN, Inc. shares.

No Form 144 notices for ACELYRIN, Inc. are on file.